Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | ACP1 | P24666 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.40 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.40 |
| ▸ | PNPO | Q9NVS9 | 1/20 | 0.40 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.40 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.40 |
| ▸ | PDXK | O00764 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1546007 | 0.98 | KDM4E (0.47) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| SCHEMBL405403 | 0.91 | HPGD (0.63) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| SCHEMBL17145899 | 0.89 | LMNA (0.60) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| SCHEMBL20581812 | 0.86 | KDM4E (0.42) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| SCHEMBL20143334 | 0.84 | HPGD (0.50) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| SCHEMBL6266333 | 0.81 | CA2 (0.46) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| SCHEMBL23054799 | 0.80 | MAPT (0.35) | KDM4EALDH1A1HSD17B10HPGDESR1 | |
| SCHEMBL19233567 | 0.80 | MAPT (0.35) | KDM4EALDH1A1HSD17B10HPGDMEN1 | |
| SCHEMBL1546656 | 0.80 | TDP1 (0.46) | KDM4EALDH1A1HSD17B10HPGDLMNA | |
| Acetic Acid SCHEMBL6266322 | 0.79 | CA2 (0.44) | KDM4EALDH1A1HSD17B10HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293458-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230293458-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2023-09-21 | — | — | US | disclosed |
| WO-2015132577-A1 | PYRIDINE DERIVATIVES AND METHODS OF USE | LINK TECHNOLOGIES LIMITED (GB) | 2015-09-11 | — | — | WO | disclosed |
| EP-2311847-B9 | COMPOSITION CONTAINING STABLE VITAMIN B6 DERIVATIVE | DAIICHI FINE CHEM CO LTD (JP) | 2013-07-24 | — | — | EP | disclosed |
| EP-2311847-B1 | COMPOSITION CONTAINING STABLE VITAMIN B6 DERIVATIVE | DAIICHI FINE CHEM CO LTD (JP) | 2013-03-27 | — | — | EP | disclosed |
| US-8003615-B2 | Stable vitamin B6 derivative | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| EP-2311847-A1 | Composition containing stable vitamin B6 derivative | Daiichi Fine Chemical Co., Ltd. (JP) | 2011-04-20 | — | — | EP | disclosed |
| US-20090117064-A1 | STABLE VITAMIN B6 DERIVATIVE | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20070148108-A1 | Stable vitamin b6 derivative | KYOWA PHARMA CHEMICAL CO., LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1679316-A1 | STABLE VITAMIN B6 DERIVATIVE | Daiichi Fine Chemical Co., Ltd. (JP) | 2006-07-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090117064-A1 | STABLE VITAMIN B6 DERIVATIVE | PNPO, PLPBP, OGFOD1 | KDM4E 1685/4885ALDH1A1 466/4885HSD17B10 537/4885 |
| US-20070148108-A1 | Stable vitamin b6 derivative | PNPO, PLPBP, OGFOD1 | KDM4E 1777/4885ALDH1A1 894/4885HSD17B10 972/4885 |
| US-20230293458-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | SI, FABP2, CEL | KDM4E 2438/4885ALDH1A1 1112/4885HSD17B10 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.